https://www.selleckchem.com/pr....oducts/Gemcitabine-H
9%), 11 (16.9%), and 4 patients (6.2%), respectively. Ursodeoxycholic acid (UDCA) was administered to 54 patients (83.1%), leading to stone dissolution in 22 patients (33.8%) within 6 months. Cholecystectomy was performed in 18 patients (27.7%) (mean age, 11.9±5.1 years). Most patients treated surgically had multiple stones (83%) and stones measuring 5 mm in size (89%), and 66.7% of patients had cholesterol stones. Cholecystectomy is feasible in patients with small-sized or large numbers of GS and those wit
Like
Comment
Share
